EPO and myeloproliferative disorder: In this case, the index patient was also found to have a persistently high hemoglobin level with suppressed erythropoietin level despite a negative panel for mutations of myeloproliferative disease and absent bone marrow biopsy evidence of clonal red cell disorder.